# Safety of DNP007 in Healthy Subjects

> **NCT06400771** · PHASE1 · RECRUITING · sponsor: **Seoul National University Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Liver Transplant Rejection
- Liver Transplant; Complications
- Steatohepatitis, Nonalcoholic

## Interventions

- **DRUG:** DNP007

## Key facts

- **NCT ID:** NCT06400771
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-10
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06400771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06400771, "Safety of DNP007 in Healthy Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06400771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*